RLMD compared with TARA: revenue, margins and what each company keeps, and the suppliers and customers both name

RLMDRelmada Therapeutics, Inc.

Mkt capRevenueRevenue

TARAProtara Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

RLMDRelmada Therapeutics, Inc.

TARAProtara Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

RLMD1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±12.8%▼−8.01%×0.63

TARA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±26.9%▲+7.98%×0.30

Q2 FY26±21.5%▼−4.87%×0.23

= impliedRLMD realized, solidTARA realized, hatchedOne scale, both sides: full bar = 27%× = |realized| ÷ impliedSource: market data

May 13 '26

±13.2%

▲+0.97%

×0.08

Q1 FY26±17.9%▼−0.70%×0.04

RLMDRelmada Therapeutics, Inc.

3.91▲+3.58%· post 3.91

Mkt cap$438.3M

TARAProtara Therapeutics, Inc.

2.28▲+7.04%· post 2.28

ClosedNov 6 '26

Mkt cap$144.6M

Compare

ClosedNov 6 '26

RLMDRelmada Therapeutics, Inc.

TARAProtara Therapeutics, Inc.

3.91▲+3.58%post 3.91

Price

2.28▲+7.04%post 2.28

$438.3M

Mkt cap

$144.6M

RLMD3.91▲+3.58%vsTARA2.28▲+7.04%ClosedNov 6 '26